文献速递脑血管病

灌注参数对后循环动脉卒中血管内治疗结局与安全性的作用

Role of Perfusion Parameters on Outcomes and Safety of Endovascular Therapy in Posterior Cerebral Artery Stroke.
PubMed 文献 · Stroke · 2026-07-09

本研究为PLATO登记的事先指定二次分析,纳入443例单侧孤立性后循环动脉闭塞且基线有灌注影像的成人患者,评估灌注参数与90天极佳结局的关系及对血管内治疗效应的修饰作用。结果发现较大的低灌注体积与极佳结局几率降低独立相关,但灌注参数未识别出血管内治疗获益人群,反而核心体积增大与治疗相关残疾移位更差及死亡风险升高相关,低灌注体积增大与症状性颅内出血风险升高相关。

要点

  • 较大低灌注体积与90天极佳结局几率降低独立相关(校正OR 0.72)。
  • 灌注参数未显示与血管内治疗获益的交互作用。
  • 核心体积增大时血管内治疗与更差残疾移位及更高死亡风险相关。

核心结论

  • 在孤立性后循环动脉闭塞中,灌注影像提供独立预后信息,但未识别出可能从血管内治疗获益的患者,反而可能提示手术风险较高的人群。

研究设计与样本

  • 国际多中心观察性PLATO登记(35中心、10国家、2015-2025年)的事先指定二次分析。
  • 纳入443例单侧孤立性后循环动脉闭塞且基线有灌注影像(CT或MRI)的连续成人患者,中位年龄74岁,女性41.8%。

主要发现

  • 较大的低灌注体积与90天极佳结局(改良Rankin量表评分0-1)几率降低独立相关(校正OR 0.72,95%CI 0.58-0.89,每1单位自然对数转换体积增加)。
  • 灌注参数与血管内治疗对主要结局无交互作用。
  • 核心体积增大与血管内治疗相比药物治疗的改良Rankin量表评分移位 progressively 更差相关(OR比值 0.66,95%CI 0.48-0.90;交互P=0.009)。
  • 核心体积增大与血管内治疗相比药物治疗的死亡风险升高相关(OR比值 1.82,95%CI 1.10-3.03;交互P=0.021)。
  • 低灌注体积增大与血管内治疗的症状性颅内出血风险升高相关(OR比值 10.15,95%CI 1.06-96.93;交互P=0.044)。

临床怎么用

  • 对孤立性后循环动脉闭塞患者,基线灌注参数可用于预后评估,但不应单独用于筛选血管内治疗获益人群。
  • 核心体积较大或低灌注体积较大的患者接受血管内治疗时需警惕残疾加重、死亡或症状性颅内出血风险升高。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The optimal management of isolated posterior cerebral artery occlusion (iPCAO) remains unclear. We investigated whether baseline perfusion imaging parameters are associated with clinical outcomes and whether they modify the association between endovascular therapy (EVT) and outcomes in iPCAO. METHODS: This prespecified secondary analysis of the international, multicenter, observational PLATO (Posterior Cerebral Artery Occlusion) registry (35 centers, 10 countries, 2015-2025) included consecutive adults with unilateral iPCAO and baseline perfusion imaging (computed tomography or magnetic resonance imaging) with reconstructed parameters. The primary end point was an excellent 90-day outcome (modified Rankin Scale score, 0-1). Perfusion parameters included hypoperfusion volume, infarct core volume, and mismatch ratio. The primary analysis used multivariable mixed-effects regression models (center as random effect) to assess associations between perfusion parameters and outcomes, adjusting for age, sex, treatment year, prestroke modified Rankin Scale score, baseline National Institutes of Health Stroke Scale score, diabetes, stroke cause, posterior circulation Acute Stroke Prognosis Early Computed Tomography Score, occlusion site, intravenous thrombolysis, and onset-to-door time. To test whether the association between EVT and outcomes varies according to baseline perfusion parameters, we evaluated treatment-by-perfusion interactions by including interaction terms (treatment×perfusion parameter) in inverse probability of treatment weighting-adjusted models, with results expressed as ratios of odds ratios (ORs). RESULTS: Of 1811 patients with iPCAO, 443 met inclusion criteria (median age, 74 years; 41.8% female). Larger hypoperfusion volume was associated with lower odds of excellent outcome (adjusted OR, 0.72 [95% CI, 0.58-0.89] per 1-unit increase in natural logarithm-transformed volume). No interaction between perfusion parameters and EVT was observed for the primary outcome. However, increasing core volume was associated with a progressively less favorable modified Rankin Scale score shift (ratio of OR, 0.66 [95% CI, 0.48-0.90]; Pinteraction=0.009) and higher mortality (ratio of OR, 1.82 [95% CI, 1.10-3.03]; Pinteraction=0.021) with EVT compared with medical management. Increasing hypoperfusion volume was associated with a higher risk of symptomatic intracranial hemorrhage with EVT (ratio of OR, 10.15 [95% CI, 1.06-96.93]; Pinteraction=0.044). CONCLUSIONS: In iPCAO, perfusion imaging provides independent prognostic information but does not identify patients with potential benefit from EVT and may instead indicate those at higher procedural risk. REGISTRATION: URL: https://osf.io/62mwt; Unique identifier: NCT05291637.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Diel NJ, Strambo D, Abdalkader M, et al. Role of Perfusion Parameters on Outcomes and Safety of Endovascular Therapy in Posterior Cerebral Artery Stroke. Stroke. 2026. PMID: 42422957. doi:10.1161/STROKEAHA.126.055949

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。